SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-025841
Filing Date
2023-07-27
Accepted
2023-07-27 09:23:28
Documents
17
Period of Report
2023-07-27
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20230727.htm   iXBRL 8-K 36122
2 EX-99.1 aquestiveannouncestoplined.htm EX-99.1 26776
6 GRAPHIC image_0.jpg GRAPHIC 402580
7 GRAPHIC image_1.jpg GRAPHIC 23557
8 GRAPHIC image_2.jpg GRAPHIC 16830
9 GRAPHIC image_3.jpg GRAPHIC 8685
  Complete submission text file 0001628280-23-025841.txt   821235

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20230727.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20230727_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20230727_pre.xml EX-101.PRE 13039
11 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20230727_htm.xml XML 2818
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 231115500
SIC: 2834 Pharmaceutical Preparations